Manufacturer
12 recalls in our database name Montana Compounding Pharmacy as the manufacturing or recalling firm.
Of the 12 recalls from Montana Compounding Pharmacy we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 12 (100%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Montana Compounding Pharmacy is recalling Trimix injectable vials because FDA inspectors observed objectionable conditions that raise concerns about the product's sterility.
Montana Compounding Pharmacy is recalling Hyaluronidase Injectable Solution because FDA inspectors observed objectionable conditions that raised concerns about the product's sterility.
Montana Compounding Pharmacy is recalling 20 vials of Glutathione Inhalation solution because objectionable conditions were observed during an FDA inspection, raising concerns about sterility.
Montana Compounding Pharmacy is recalling specific lots of Glutathione Nasal Solution because FDA inspectors observed objectionable conditions that raise concerns about the product's sterility.
Montana Compounding Pharmacy is recalling Alprostadil injectable vials due to lack of assurance of sterility and objectionable conditions observed during an FDA inspection.
Montana Compounding Pharmacy is recalling specific lots of Trimix injectable vials because FDA inspectors observed objectionable conditions that raise concerns about sterility.
Montana Compounding Pharmacy is recalling Bimix injectable vials because FDA inspectors observed objectionable conditions that raise concerns about sterility assurance.
Montana Compounding Pharmacy is recalling Alprostadil injectable vials due to lack of assurance of sterility and objectionable conditions observed during an FDA inspection.
Montana Compounding Pharmacy is recalling specific lots of Trimix injectable vials due to lack of assurance of sterility observed during an FDA inspection.
Montana Compounding Pharmacy is recalling Alprostadil injectable vials because objectionable conditions were observed during an FDA inspection, raising concerns about sterility.
Montana Compounding Pharmacy is recalling specific lots of Trimix injectable vials because FDA inspectors observed objectionable conditions that raise concerns about sterility.
Montana Compounding Pharmacy is recalling Avastin syringes because FDA inspectors observed objectionable conditions that raise concerns about sterility.